Campylobacter ureolyticus – an emerging gastrointestinal pathogen?

EntericBio was used in a study performed by Bullman et al. in which

7,149 faecal samples were tested. Of 349 campylobacter-positive samples, 23.8% were shown to be Campylobacter ureolyticus, using a combination of 16S rRNA analysis and highly specific primers targeting the HSP60 gene of this organism. This is, to the best of their knowledge, the first report of C. ureolyticus in the faeces of patients presenting with gastroenteritis and may suggest a role for this organism as an emerging enteric pathogen.

more info click here

Home	Test Process	Technical	Certificates	News	Distributors	Contact	EntericBio

January 2011
EntericBio was exhibited in Dubai, at Arab Health 2011. The product generated great interest.

November 2010
Campylobacter ureolyticus – an emerging gastrointestinal pathogen? EntericBio was used in a study performed by Bullman et al. in which 7,149 faecal samples were tested. Of 349 campylobacter-positive samples, 23.8% were shown to be Campylobacter ureolyticus, using a combination of 16S rRNA analysis and highly specific primers targeting the HSP60 gene of this organism. This is, to the best of their knowledge, the first report of C. ureolyticus in the faeces of patients presenting with gastroenteritis and may suggest a role for this organism as an emerging enteric pathogen. more info click here
EntericBio Faceal Pathogen Detection Kit was installed in *Inkosi Albert Luthuli Central Hospital, South Africa.* Dermot Scanlon, pictured opposite at IALCH, said that the test was very well received by the laboratory staff. The kit will improve both the quality of the diagnostic result and the efficiency of the laboratory.
EntericBio exhibited at Medica 2010, held in Düsseldorf Germany.


April 2010 EntericBio was exhibited at BioMedica in Dublin.



November 2009 EntericBio was exhibited at Medica 2009.


September 2009 EntericBio was the subject of a scientific paper "Comparison of the EntericBio® multiplex PCR system with routine culture for the detection of the bacterial enteric pathogens." The work was performed by James O'Leary, Daniel Corcoran, and Brigid Lucey - Department of Medical Microbiology, Cork University Hospital, Wilton, Cork, Ireland. The paper was published in the Journal of Clinical Microbiology - J. Clin. Microbiol. doi:10.1128/JCM.01026-09 - to read the abstract click here The EntericBio product and process was audited during a recent CPA audit of Cork University Microbiology Department. EntericBio passed the audit without any issues being raised by CPA. CPA provides a means to accredit Clinical Pathology Services and External Quality Assessment Schemes (EQA). It involves an external audit of the ability to provide a service of high quality by declaring a defined standard of practice, which is confirmed by peer review.


September 2009 EntericBio was exhibited at IBMS Congress, Birmingham Sept 28th - 30th



May 2009 EntericBio was exhibited at ECCMID in May.



January 2009 EntericBio is used routinely in the Microbiology Department at CUH, to detect Campylobacter, Shigella, E coli 0157 & Salmonella in faecal samples.



© Serosep Ltd 2010, Annacotty Business Park, Annacotty, Co. Limerick, Ireland. Tel +353 61 358190 Email info@serosep.com